Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Thalassax Therapeutics United States Ltd

Clinical trials sponsored by Thalassax Therapeutics United States Ltd, explained in plain language.

Not yet recruiting 1

New drug CS231295 enters first human trial for tough cancers

Disease control Not yet recruiting

This early-stage trial tests a new drug called CS231295 in 42 adults with advanced solid tumors that have stopped responding to standard treatments. The drug works by blocking certain proteins that help tumors grow and form blood vessels. The main goals are to check safety, find …

Phase 1 • Sponsor: ThalassaX Therapeutics United States Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:39 UTC